MedPath

Chinese Academy of Sciences

Chinese Academy of Sciences logo
🇨🇳China
Ownership
Private
Established
1949-01-01
Employees
10K
Market Cap
-
Website
http://www.cas.cn

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Conditions
Human Influenza
First Posted Date
2010-03-31
Last Posted Date
2010-04-12
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
20
Registration Number
NCT01096225
Locations
🇨🇳

Institute of microbiology, Chinese Academy of Sciences, Beijing, Beijing, China

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects

Not Applicable
Completed
Conditions
Genotype
Pharmacokinetic
Interventions
First Posted Date
2010-03-09
Last Posted Date
2010-03-09
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
14
Registration Number
NCT01082796
Locations
🇨🇳

Departmant of Clinical Pharmacology, the First Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, China

Brown Rice Intervention on Metabolic Syndrome (BRIMS)

Phase 2
Completed
Conditions
Metabolic Syndrome X
First Posted Date
2009-12-01
Last Posted Date
2010-10-21
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
202
Registration Number
NCT01022411
Locations
🇨🇳

Institute for Nutritional Sciences, Chinese Academy of Sciences, Shanghai, China

Clinical Pharmacokinetics Study on Pikamilone

Completed
Conditions
Healthy
First Posted Date
2009-07-15
Last Posted Date
2009-07-15
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
30
Registration Number
NCT00940186
Locations
🇨🇳

the second hospital to liaoning university of TCM, Shenyang, Liaoning, China

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide

Completed
Conditions
Healthy
First Posted Date
2008-12-10
Last Posted Date
2010-01-27
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
36
Registration Number
NCT00806013
Locations
🇨🇳

The second hospital to Liaoning University of TCM, Shenyang, Liaoning, China

Walnut Intervention on Metabolic Syndrome (WIMS)

Phase 2
Completed
Conditions
Metabolic Syndrome X
First Posted Date
2008-08-28
Last Posted Date
2015-02-05
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
189
Registration Number
NCT00742742
Locations
🇨🇳

Institute for Nutritional Sciecnes, Chinese Acadamy of Sciences, Shanghai, China

Flaxseed Intervention on Metabolic Syndrome

Phase 2
Completed
Conditions
Metabolic Syndrome X
First Posted Date
2008-08-13
Last Posted Date
2015-02-05
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
189
Registration Number
NCT00733772
Locations
🇨🇳

Institute for Nutritional Sciences, Chinese Academy of Sciences, Shanghai, Shanghai, China

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

Phase 3
Conditions
Non-small Cell Lung Cancer
Interventions
First Posted Date
2007-12-19
Last Posted Date
2010-03-09
Lead Sponsor
Chinese Academy of Sciences
Target Recruit Count
1108
Registration Number
NCT00576914
Locations
🇨🇳

The Lung Cancer Center of Cancer Hospital, Beijing, Beijing, China

A Bilateral Interconnected DIEP Flap Based on One Vessel Pedicle for Breast Reconstruction

Not Applicable
Completed
Conditions
Mammaplasty
First Posted Date
2007-08-10
Last Posted Date
2009-06-24
Lead Sponsor
Chinese Academy of Sciences
Registration Number
NCT00514748
Locations
🇨🇳

Plastic Surgery Hospital, Beijing, China

Dual-Plane Breast Augmentation: Axillary Approach With Assistant of Endoscope

Phase 1
Completed
Conditions
Mammoplasty
First Posted Date
2007-07-23
Last Posted Date
2009-06-24
Lead Sponsor
Chinese Academy of Sciences
Registration Number
NCT00505557
Locations
🇨🇳

Plastic Surgery Hospital Affilicated to Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath